<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//rapt.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-strengthens-board-with-addition-of-veteran-biotechnology-executive-wendye-robbins-m-d/</loc>
		<lastmod>2019-10-25T10:20:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-appoints-rodney-young-as-chief-financial-officer/</loc>
		<lastmod>2019-12-04T15:15:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/bristol-myers-squibb-to-expand-its-immuno-oncology-pipeline-with-agreement-to-acquire-flexus-biosciences-inc/</loc>
		<lastmod>2022-12-07T19:24:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-announces-senior-management-hires-and-initiation-of-phase-1-trial-of-flx925/</loc>
		<lastmod>2022-12-09T19:48:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-hires-senior-leaders-in-immuno-oncology-drug-discovery/</loc>
		<lastmod>2023-02-07T04:48:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-completes-leadership-team-in-immuno-oncology-drug-discovery/</loc>
		<lastmod>2023-02-23T17:40:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-announces-50-million-series-b-financing/</loc>
		<lastmod>2023-03-24T20:48:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/cofactor-genomics-partners-with-flx-bio-for-immuno-oncology-analysis-platform/</loc>
		<lastmod>2023-04-10T20:52:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-announces-poster-presentations-at-the-american-society-of-hematology-conference-on-flx925-a-small-molecule-flt3-cdk4-6-inhibitor/</loc>
		<lastmod>2023-05-03T09:35:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-inc-appoints-linda-kozick-to-its-board-of-directors/</loc>
		<lastmod>2023-05-10T20:43:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-to-present-poster-at-the-american-association-of-cancer-research-aacr-conference-on-its-lead-immuno-oncology-program-targeting-ccr4/</loc>
		<lastmod>2023-05-25T21:00:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-adds-distinguished-immuno-oncology-experts-to-its-scientific-advisory-board/</loc>
		<lastmod>2023-06-07T11:11:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-selects-immuno-oncology-clinical-candidate/</loc>
		<lastmod>2023-08-11T12:01:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-the-appointment-of-michael-listgarten-as-general-counsel-2/</loc>
		<lastmod>2023-08-28T22:06:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-to-present-at-evercore-isi-2017-biopharma-catalyst-deep-dive-conference/</loc>
		<lastmod>2023-08-29T15:44:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-completes-60-million-series-c-financing/</loc>
		<lastmod>2023-10-02T22:04:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-appoints-dirk-g-brockstedt-ph-d-as-senior-vice-president-of-biology/</loc>
		<lastmod>2023-10-30T16:10:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-adds-distinguished-biopharma-industry-leader-michael-giordano-m-d-to-board-of-directors/</loc>
		<lastmod>2023-11-03T14:45:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-to-present-at-rbc-capital-markets-2018-global-healthcare-conference/</loc>
		<lastmod>2023-11-07T19:01:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-to-highlight-new-preclinical-data-from-ccr4-and-usp7-programs-at-the-american-academy-for-cancer-research-annual-meeting/</loc>
		<lastmod>2023-11-20T04:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-to-present-at-the-jefferies-global-healthcare-conference/</loc>
		<lastmod>2023-12-12T16:04:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-to-present-at-the-2018-wedbush-pacgrow-healthcare-conference/</loc>
		<lastmod>2024-01-31T08:42:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-announces-first-patient-dosed-with-flx475-a-best-in-class-ccr4-inhibitor-for-the-treatment-of-multiple-cancers/</loc>
		<lastmod>2024-02-13T12:36:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/fiercebiotech-names-flx-bio-as-one-of-its-fierce-15-biotech-companies-of-2018/</loc>
		<lastmod>2024-02-20T12:04:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-announces-clinical-trial-collaboration-agreement-with-merck-for-ongoing-phase-1-2-study-of-flx475/</loc>
		<lastmod>2024-03-05T20:05:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-highlights-phase-1-data-for-flx475-at-sitc-2018/</loc>
		<lastmod>2024-03-07T12:38:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-to-present-at-evercore-isi-healthconx-conference/</loc>
		<lastmod>2024-04-09T15:19:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-to-present-at-37th-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2024-05-09T11:19:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-to-present-at-cowen-and-company-39th-annual-health-care-conference/</loc>
		<lastmod>2024-08-08T11:57:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-highlights-preclinical-atopic-dermatitis-and-asthma-data-for-flx193-at-the-american-association-of-immunologists-aai-annual-meeting-2019/</loc>
		<lastmod>2024-11-11T11:46:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/personalis-enters-into-a-research-agreement-with-flx-bio-to-provide-comprehensive-tumor-immunogenomic-profiling-for-clinical-study/</loc>
		<lastmod>2024-11-12T12:08:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/flx-bio-announces-name-change-to-rapt-therapeutics/</loc>
		<lastmod>2024-12-23T10:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-completes-37-million-series-c-extension/</loc>
		<lastmod>2024-12-23T12:04:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-150-million-private-placement/</loc>
		<lastmod>2024-12-23T14:04:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-the-appointment-of-emma-guttman-yassky-m-d-ph-d-a-leading-expert-in-the-field-of-inflammatory-skin-diseases-to-its-scientific-advisory-board/</loc>
		<lastmod>2025-01-04T10:07:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-promotion-of-key-research-and-development-senior-leaders/</loc>
		<lastmod>2025-01-07T22:15:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-strengthens-board-with-addition-of-veteran-biotechnology-executive-wendye-robbins-m-d-2/</loc>
		<lastmod>2025-03-06T11:39:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-initiation-of-first-in-human-phase-1-study-of-rpt193/</loc>
		<lastmod>2025-03-07T19:55:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-fourth-quarter-and-full-year-2024-financial-results/</loc>
		<lastmod>2025-03-16T12:14:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-participate-in-upcoming-investor-conferences-2/</loc>
		<lastmod>2025-03-16T12:14:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-150-million-private-placement-2/</loc>
		<lastmod>2025-03-16T12:14:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-names-lori-lyons-williams-chair-of-the-companys-board-of-directors/</loc>
		<lastmod>2025-03-16T12:14:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-43rd-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-second-quarter-2024-financial-results/</loc>
		<lastmod>2025-03-16T12:14:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/based-on-recent-fda-feedback-rapt-therapeutics-stops-zelnecirnon-program-following-clinical-hold-due-to-single-sae-of-severe-liver-injury/</loc>
		<lastmod>2025-03-16T12:14:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-third-quarter-2024-financial-results/</loc>
		<lastmod>2025-03-16T12:14:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-and-shanghai-jemincare-pharmaceutical-announce-exclusive-license-agreement-for-novel-long-acting-anti-ige-antibody/</loc>
		<lastmod>2025-03-16T12:14:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-promising-results-from-phase-2-trial-of-tivumecirnon-in-combination-with-anti-pd-1-immunotherapy-in-cpi-experienced-head-and-neck-cancer-patients/</loc>
		<lastmod>2025-03-16T12:14:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-first-quarter-2024-financial-results/</loc>
		<lastmod>2025-03-16T12:14:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-bolsters-leadership-team-with-the-appointment-of-nipun-davar-ph-d-as-senior-vice-president-of-technical-operations/</loc>
		<lastmod>2025-03-16T12:14:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-clinical-hold-on-studies-evaluating-zelnecirnon/</loc>
		<lastmod>2025-03-16T12:14:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-multiple-late-breaking-presentations-at-the-upcoming-american-association-for-cancer-research-aacr-annual-meeting/</loc>
		<lastmod>2025-03-16T12:14:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-fourth-quarter-and-full-year-2023-financial-results/</loc>
		<lastmod>2025-03-16T12:14:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-third-quarter-2023-financial-results/</loc>
		<lastmod>2025-03-16T12:14:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-publication-of-phase-1a-1b-clinical-trial-of-zelnecirnon-rpt193-to-treat-atopic-dermatitis-in-allergy/</loc>
		<lastmod>2025-03-16T12:14:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-participate-in-the-guggenheim-healthcare-talks-6th-annual-biotechnology-conference/</loc>
		<lastmod>2025-03-16T12:14:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september-2/</loc>
		<lastmod>2025-03-16T12:14:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-two-flx475-presentations-at-the-society-for-immunotherapy-of-cancer-sitc-2023-annual-meeting/</loc>
		<lastmod>2025-03-16T12:14:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-november/</loc>
		<lastmod>2025-03-16T12:14:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-positive-data-including-objective-response-rates-and-progression-free-survival-from-its-phase-2-trial-of-flx475-in-combination-with-a-checkpoint-inhibitor-in-patients-wit/</loc>
		<lastmod>2025-03-16T12:14:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-first-quarter-2023-financial-results/</loc>
		<lastmod>2025-03-16T12:14:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-biomarker-data-corroborating-demonstrated-clinical-activity-and-mechanism-of-action-of-flx475-in-advanced-cancers/</loc>
		<lastmod>2025-03-16T12:14:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-participate-in-the-goldman-sachs-global-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-second-quarter-2023-financial-results/</loc>
		<lastmod>2025-03-16T12:14:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-fourth-quarter-and-year-end-financial-results/</loc>
		<lastmod>2025-03-16T12:14:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-initiation-of-phase-2a-trial-of-rpt193-in-patients-with-moderate-to-severe-asthma/</loc>
		<lastmod>2025-03-16T12:14:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-flx475-poster-presentation-at-the-2023-american-society-of-clinical-oncology-asco-annual-meeting/</loc>
		<lastmod>2025-03-16T12:14:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-the-appointment-of-michael-listgarten-as-general-counsel/</loc>
		<lastmod>2025-03-16T12:14:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-presents-update-from-its-phase-1-2-clinical-trial-for-flx475-as-monotherapy-and-in-combination-with-pembrolizumab-in-patients-with-advanced-cancer/</loc>
		<lastmod>2025-03-16T12:14:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-participate-in-the-svb-securities-global-biopharma-conference/</loc>
		<lastmod>2025-03-16T12:14:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-flx475-phase-1-2-data-at-the-european-society-for-medical-oncology-esmo-immuno-oncology-annual-congress/</loc>
		<lastmod>2025-03-16T12:14:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-pricing-of-public-offering-of-common-stock-2/</loc>
		<lastmod>2025-03-16T12:14:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-proposed-public-offering-of-common-stock-2/</loc>
		<lastmod>2025-03-16T12:14:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-third-quarter-2022-financial-results/</loc>
		<lastmod>2025-03-16T12:14:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-strengthens-leadership-team-with-two-new-key-hires/</loc>
		<lastmod>2025-03-16T12:14:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences-in-september/</loc>
		<lastmod>2025-03-16T12:14:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-second-quarter-2022-financial-results/</loc>
		<lastmod>2025-03-16T12:14:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-participate-in-several-upcoming-investor-conferences/</loc>
		<lastmod>2025-03-16T12:14:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-expands-leadership-team-with-multiple-key-hires/</loc>
		<lastmod>2025-03-16T12:14:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-first-quarter-2022-financial-results/</loc>
		<lastmod>2025-03-16T12:14:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-private-placement-financing-of-50-million/</loc>
		<lastmod>2025-03-16T12:14:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-initiation-of-phase-2b-trial-of-rpt193-in-patients-with-moderate-to-severe-atopic-dermatitis/</loc>
		<lastmod>2025-03-16T12:14:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-participate-in-the-11th-annual-svb-leerink-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-fourth-quarter-and-year-end-2021-financial-results/</loc>
		<lastmod>2025-03-16T12:14:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-biomarker-data-from-phase-1b-trial-of-rpt193-consistent-with-disease-modification-in-atopic-dermatitis/</loc>
		<lastmod>2025-03-16T12:14:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-third-quarter-2021-financial-results/</loc>
		<lastmod>2025-03-16T12:14:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-appoints-industry-veteran-lori-lyons-williams-to-its-board-of-directors/</loc>
		<lastmod>2025-03-16T12:14:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-40th-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-rpt193-phase-1b-data-at-30th-european-academy-of-dermatology-and-venereology-congress/</loc>
		<lastmod>2025-03-16T12:14:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-late-breaking-oral-presentation-of-positive-results-from-phase-1b-trial-of-rpt193-at-the-30th-european-academy-of-dermatology-and-venereology-congress/</loc>
		<lastmod>2025-03-16T12:14:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-upcoming-oral-presentation-of-rpt193-phase-1b-data-at-the-4th-inflammatory-skin-disease-summit/</loc>
		<lastmod>2025-03-16T12:14:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-participate-in-upcoming-investor-conferences/</loc>
		<lastmod>2025-03-16T12:14:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-second-quarter-2021-financial-results/</loc>
		<lastmod>2025-03-16T12:14:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-2021-cantor-virtual-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-upcoming-investor-conferences/</loc>
		<lastmod>2025-03-16T12:14:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-pricing-of-public-offering-of-common-stock/</loc>
		<lastmod>2025-03-16T12:14:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-proposed-public-offering-of-common-stock/</loc>
		<lastmod>2025-03-16T12:14:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-positive-topline-results-from-phase-1b-trial-of-rpt193-monotherapy-in-atopic-dermatitis/</loc>
		<lastmod>2025-03-16T12:14:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares/</loc>
		<lastmod>2025-03-16T12:14:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-ubs-global-healthcare-virtual-conference/</loc>
		<lastmod>2025-03-16T12:14:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-first-quarter-2021-financial-results/</loc>
		<lastmod>2025-03-16T12:14:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-report-top-line-data-from-phase-1b-trial-of-rpt193-in-atopic-dermatitis/</loc>
		<lastmod>2025-03-16T12:14:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-completes-enrollment-in-phase-1b-trial-of-rpt193-in-atopic-dermatitis/</loc>
		<lastmod>2025-03-16T12:14:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-fourth-quarter-and-year-end-2020-financial-results/</loc>
		<lastmod>2025-03-16T12:14:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-report-promising-preclinical-studies-supporting-its-pipeline-of-immunotherapy-platforms-at-aacr/</loc>
		<lastmod>2025-03-16T12:14:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-participate-in-two-investor-conferences-in-march/</loc>
		<lastmod>2025-03-16T12:14:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-piper-sandler-32nd-annual-virtual-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-10th-annual-svb-leerink-global-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-third-quarter-2020-financial-results/</loc>
		<lastmod>2025-03-16T12:14:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-positive-initial-data-from-ongoing-phase-1-2-clinical-trial-of-flx475-in-multiple-cancer-indications/</loc>
		<lastmod>2025-03-16T12:14:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-announce-initial-data-from-phase-1-2-clinical-trial-of-flx475-in-multiple-cancer-indications/</loc>
		<lastmod>2025-03-16T12:14:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-stifel-2020-virtual-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-appoints-phyllis-loud-gray-as-vice-president-of-human-resources/</loc>
		<lastmod>2025-03-16T12:14:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-second-quarter-2020-financial-results/</loc>
		<lastmod>2025-03-16T12:14:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-upcoming-virtual-investor-conferences/</loc>
		<lastmod>2025-03-16T12:14:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-appoints-lisa-butterfield-ph-d-and-lawrence-fong-m-d-to-scientific-advisory-board/</loc>
		<lastmod>2025-03-16T12:14:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-poster-presentation-at-the-american-society-of-clinical-oncology-virtual-scientific-program/</loc>
		<lastmod>2025-03-16T12:14:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-bmo-2020-prescriptions-for-success-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/peter-svennilson-elected-to-rapt-therapeutics-board-of-directors/</loc>
		<lastmod>2025-03-16T12:14:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-highlights-early-results-for-rpt193-at-society-for-investigative-dermatology-meeting/</loc>
		<lastmod>2025-03-16T12:14:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-first-quarter-2020-financial-results/</loc>
		<lastmod>2025-03-16T12:14:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-ubs-virtual-global-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-jefferies-virtual-global-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-upcoming-investor-conference-presentations/</loc>
		<lastmod>2025-03-16T12:14:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-pricing-of-75-million-public-offering/</loc>
		<lastmod>2025-03-16T12:14:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-management-promotions/</loc>
		<lastmod>2025-03-16T12:14:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-fourth-quarter-2019-financial-results-and-provides-business-update/</loc>
		<lastmod>2025-03-16T12:14:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-proposed-offering-of-common-stock/</loc>
		<lastmod>2025-03-16T12:14:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-present-at-the-38th-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2025-03-16T12:14:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-to-be-added-to-the-russell-2000-and-russell-microcap-indices/</loc>
		<lastmod>2025-03-16T12:14:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-and-hanmi-pharmaceutical-announce-collaboration-to-develop-and-commercialize-flx475-in-asia/</loc>
		<lastmod>2025-03-16T12:14:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-appoints-rodney-young-as-chief-financial-officer-2/</loc>
		<lastmod>2025-03-16T12:14:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-reports-third-quarter-2019-financial-results-and-recent-highlights/</loc>
		<lastmod>2025-03-16T12:14:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-appoints-mary-ann-gray-ph-d-to-board-of-directors/</loc>
		<lastmod>2025-03-16T12:14:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://rapt.com/news/rapt-therapeutics-announces-pricing-of-initial-public-offering/</loc>
		<lastmod>2025-03-16T12:15:00+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->